ARTICLE | Company News

Soligenix, SciClone deal

September 19, 2016 7:00 AM UTC

The partners added commercialization and development rights in Taiwan, South Korea and Vietnam to a 2013 deal granting SciClone rights to develop and market SGX942 in China, including Hong Kong and Macau, to treat oral mucositis. Soligenix retains worldwide manufacturing rights and will provide the compound to SciClone on a cost-plus basis. ...